MIAT and B-cell chronic lymphocytic leukemia: In addition, it has been demonstrated that high expression of MIAT in peripheral blood mononuclear cells of CLL patients is associated with adverse prognostic markers such as high and intermediate risk cytogenetics (del17p, del11q and trisomy 12) and unmutated IGHV status, as well as with shorter overall survival [197].